Press release
Smart Compound Stewardship for DMPK: WuXi AppTec DMPK's Automated Compound Management with Full-Process Traceability
Leveraging over 15 years of laboratory operational expertise, WuXi AppTec (https://www.wuxiapptec.com/) DMPK has provided compound management services to thousands of pharmaceutical and biotechnology companies worldwide, supporting a storage capacity of over one million compounds. The platform enables "full lifecycle compound management" through digital intelligent operations, ensuring end-to-end visibility and traceability from receipt to disposal to minimize human error. Core capabilities include automated robotic retrieval under various storage conditions, real-time integration of weighing data with high-precision balances, and automated separation and preparation via Hamilton systems-ensuring compounds are pre-prepared to significantly reduce wait times and accelerate project turnaround. Furthermore, the solution integrates real-time logistics tracking, image recognition-based automated picking, high-density mobile storage, and tamper-proof audit logs, seamlessly interfacing with the Mosaic Compound Management System to create a secure and transparent intelligent management loop.Meanwhile, we have established a standardized cross-border compliance framework offering efficient import and export services, featuring full-process visualization and early regulatory intervention support for global markets, thereby significantly reducing logistical delays and compliance risks in international R&D collaborations.
Why does rigorous compound stewardship matter for R&D success?
Compound management in DMPK faces three major challenges: diverse container types, very large compound libraries, and strict storage-condition requirements. Automation depends on standardizing consumables. WuXi AppTec DMPK has developed a comprehensive compound lifecycle management system that integrates hardware, software, image-based recognition, automated handling, and systems integration to deliver automated, auditable, and scalable compound stewardship suitable for regulated and quality-conscious environments.
How do we enable real-time logistics tracking and full-process traceability?
We achieve full-process traceability through three core capabilities: realtime logistics synchronization, comprehensive lifecycle logging, and automated in-storage management via the Smart Compound Library.
1.Real-time package logistics and synchronized metadata
When a customer or third-party ships a package, our system initiates continuous monitoring based on the tracking number. Automated alerts are sent to designated receivers based on pick-up and transit milestones to ensure timely attention and safe, on-schedule delivery. Real-time logistics data are synchronized and stored in our system, compensating for delays inherent in querying third-party waybill histories, and enabling one-click traceability that links each specific compound to its parcel and live transit status. The system supports integration with third-party courier platforms via API to keep metadata synchronized and tamper-evident.
2.Full-process lifecycle management with tamper-evident logs
Our whole-process management records every timestamp from dispatch and sign-off to internal transfers and final return or disposal. The lifecycle is partitioned into three stages-pre-receipt, post-receipt, and return/disposal-with photographic capture on arrival to verify receipt time, automatic logging of intra-company transfers, and explicit time nodes for returns or destruction. All operational events (receipt photo capture, internal transfers, operators, timestamps) are preserved in tamper-evident logs to support chain-of-custody and traceability. Compound managers can access traceable logs of compound information and transfer history for internal review.
3.Smart compound library: accurate, efficient in-storage management
A.Fully automated intake and inventory
Simplified operations: no manual label scanning-place a rack on the temporary staging turntable to complete storage.
Simplified retrieval: operators add compound barcodes to a pick list; the system locates, picks, and delivers requested items to the staging area without prior knowledge of exact locations.
Automated inventory: image-based recognition and automated verification compare physical contents with database records and produce reconciliation records, enabling efficient, high-accuracy stock verification.
Traceability: all actions are logged with operator IDs and timestamps, preserving data integrity and traceability.
B.Image-based recognition for position and orientation detection
Extensive image-training establishes standard parameters for diverse tube types and well positions. When calculated parameters fall within predefined thresholds, the system confirms presence and returns coordinates and similarity metrics. Per-well recognition thresholds account for lighting and angle variability; multiple trained parameter sets support different tube specifications to increase robustness and accuracy.
C.Flexible gripping strategies for multiple container types (0.7-8 mL)
Rack barcodes identify rack types and dynamically select the appropriate gripping scheme (height, opening stroke, angle). Combining these parameters with digital imagery and recognition, the robotic system reliably grasps tubes across volumes from 0.7 to 8 mL, supporting high throughput while minimizing sample damage.
D.Temperature and humidity control and intelligent pressure protection
The smart library maintains controlled temperature and humidity conditions to protect sample integrity. Pressure sensors integrated into pick operations halt automation immediately if pressure exceeds safe thresholds, protecting tube integrity during tube-picking.
E. Mobile double-sided cabinets for high-density storage (~4×)
A movable dense-cabinet design preserves a working channel for robotic pick-and-place while maximizing storage density. Defragmentation routines further optimize rack utilization. The result is approximately fourfold storage capacity versus fixed-cabinet layouts in the same footprint-delivering meaningful space and cost efficiencies.
How secure and integrable is the system?
The system is designed to ensure data integrity, secure access, and to meet varying project throughput.
Tamper-evident recordkeeping: All lifecycle events (receipt photo capture, internal transfers, operator actions, timestamps) are recorded in immutable logs that support chain-of-custody and third-party review.
Access control and data protection: Role-based access control (RBAC), detailed operation logs, and encryption for data at rest and in transit protect sample metadata and operational records from unauthorized access.
Reliable audit support: The system provides detailed, automatically generated traceable logs regarding compound information and transfer history to support customer data transparency.
What business value and managed service options does WuXi AppTec DMPK offer?
WuXi AppTec DMPK delivers measurable operational and cost benefits through automation and high-density storage, and offers flexible managed-service models to meet diverse customer needs.
Space and cost efficiencies: Mobile dense-cabinet designs and defragmentation routines can increase effective storage density by roughly fourfold versus fixed-cabinet layouts, reducing lab footprint and associated overhead.
Labor and error reduction: Automated storage, retrieval, and image-based inventory reduce manual handling and human error, improving throughput and data consistency.
Full-process managed services: Offerings include sample receipt, secure storage, in-lab distribution, and return or destruction-available as full custodial services or tailored modules.
Conclusion
Digitalization and automation are reshaping laboratory operations. WuXi AppTec DMPK's end-to-end compound management and Smart Compound Library services seamlessly bridge front-end sample intake (including registration, structure confirmation, and QC) with back-end data and analysis workflows. We provide a one-stop solution featuring high-precision inventory management, automated retrieval and aliquoting, and real-time end-to-end traceability, ensuring data integrity and high-density storage efficiency.
This intelligent system not only significantly shortens compounds preparation turnaround times but also helps clients substantially reduce operational costs and compliance risks by eliminating manual errors and enhancing data transparency. Ultimately, it accelerates critical R&D decision-making, enabling faster, safer, and more cost-effective DMPK research.
With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform.
Email: wuxiconcierge@wuxiapptec.com
WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients-one collaboration at a time.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Smart Compound Stewardship for DMPK: WuXi AppTec DMPK's Automated Compound Management with Full-Process Traceability here
News-ID: 4567706 • Views: …
More Releases from WuXi AppTec
Which Companies Can Handle End-to-End Drug Development Smoothly?
Drug developers seeking end-to-end development support may consider several types of external partners, including integrated CRDMO platforms, full-service CROs, and specialized CDMOs. Full-service CROs and specialized CDMOs may provide deep expertise in specific stages of development. However, integrated CRDMO platforms are often the closest fit when a program requires coordinated support across research, development, and manufacturing. WuXi AppTec represents one company using this model.
End-to-End Drug Development Matters for Speed and…
Which CRO/CDMO Can Support Global Drug Development?
A CRO/CDMO that can support global drug development should combine modality-specific technical expertise, global regulatory experience, scalable manufacturing, mature quality systems, secure data infrastructure, and cross-region project governance. For complex modalities such as peptides, oligonucleotides, and antibody-drug conjugates (ADCs), an integrated CRO/CDMO or CRDMO (Contract Research Development and Manufacturing Organization) model, as illustrated by companies such as WuXi AppTec, can help reduce handoffs, manage execution risk, and support more efficient…
As New Drug Modalities Advance, WuXi AppTec Expands Global Capabilities for Pept …
The rapid rise of new therapeutic modalities - from peptides and oligonucleotides to targeted protein degraders (TPDs) and antibody-drug conjugates (ADCs) - is reshaping how medicines are developed and manufactured globally.
The scientific shift toward more structurally complex and therapeutically targeted molecules has prompted a corresponding reallocation of investment priorities at WuXi AppTec (https://www.wuxiapptec.com), with increased focus on expanding capabilities in emerging modalities such as oligonucleotides and peptides, according to Pharma…
WuXi AppTec Builds a Flexible Global Manufacturing Network Around Customer Choic …
As pharmaceutical companies increasingly seek resilient and flexible supply chains, WuXi AppTec (https://www.wuxiapptec.com) is expanding manufacturing capabilities across the United States, Europe, and Asia with a focus on giving customers more regional options while maintaining consistent global standards.
The company's latest investments include major manufacturing projects in the U.S., Switzerland, Singapore and China, spanning both drug substance and drug product production. According to the recent interview with Pharma Manufacturing, WuXi AppTec…
More Releases for DMPK
Myotonic Dystrophy Pipeline Appears Robust With 20+ Key Pharma Companies Activel …
DelveInsight's, "Myotonic Dystrophy Pipeline Insight 2026" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Myotonic Dystrophy pipeline landscape. It covers the Myotonic Dystrophy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myotonic Dystrophy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights!…
Which CRO Is Good at Protein Degradation?
Key Takeaways
An idealCRO for protein degradation combines discovery biology, medicinal chemistry, drug metabolism and pharmacokinetics (DMPK), and development expertise within an integrated platform.
WuXi AppTec helps innovators advance targeted protein degrader programs through coordinated discovery technologies, chemistry expertise, and scalable development support.
As targeted protein degradation expands across oncology, immunology, and other disease areas, integrated partners can help reduce delays, improve decisions, and accelerate progression to clinic.
Introduction
Which CRO is good at protein…
Myotonic Dystrophy Pipeline Enters a New Era of Genetic Innovation with 20+ Comp …
The Myotonic Dystrophy (DM) therapeutic landscape is witnessing a transformative shift, driven by rapid advancements in RNA-targeted therapies, gene silencing technologies, and precision medicine approaches. Leading biopharmaceutical companies such as Novartis AG, Sanofi, Arrowhead Pharmaceuticals, Arthex Biotech, and Ionis Pharmaceuticals are at the forefront of innovation, developing next-generation therapies aimed at addressing the root genetic causes of this complex neuromuscular disorder.
According to DelveInsight's latest report, "Myotonic Dystrophy Pipeline Insight 2026,"…
Drug Metabolism and Pharmacokinetics (DMPK) Market Dynamic Growth Factors, In-De …
The Latest published market study on Drug Metabolism and Pharmacokinetics (DMPK) Market report provides an overview of the current market dynamics as well as what our survey respondents- all outsourcing decision-makers- predict the market will look like in 2031. The study breaks down the market by revenue volume and price history to estimate the size and trends analysis and identify gaps and opportunities. This report provides impactful insights for our…
At 7.5% CAGR Preclinical CRO Market is Grow Widely by 2022-2030 Size, SWOT Analy …
Preclinical CRO Market Insights:
In a recent research report by Market Research Community, the preclinical CRO market is expected to surpass USD 8.82 Billion by the year 2030, from USD 4.60 Billion in 2021.
Preclinical CROs give biopharmaceutical and medical device businesses the tools and services they need to concentrate on their main business operations when developing new drugs and medical devices.
Request Sample Report @ https://marketresearchcommunity.com/sample-request/?rid=782
Top Key Players of the Preclinical CRO…
Pre-Clinical CROs Market outlook to 2027 | Charles River, Eurofins Scientific, W …
The global pre-clinical CROs market is expected to reach US$ 8,412.9 Mn in 2027 from US$ 4,282.4 Mn in 2018. The market is estimated to grow with a CAGR of 8.1% from 2019-2027.
The global pre-clinical CROs market, based on service, has been segmented into bio-analysis and DMPK studies, toxicology and other services. The toxicology segment held a largest share of the market in 2018. Moreover, the same segment is anticipated…
